|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of intangible assets | |||||
| Impairment of acquired intangible assets and licenses | |||||
| Unrealized foreign exchange differences | |||||
| Amortization of debt discount and transaction costs | |||||
| Impairment of acquired intangible assets, licenses, property and equipment | |||||
| Stock-based compensation expense | |||||
| Excess tax benefits from stock-based compensation | |||||
| Gain on the disposal of property, equipment and intangible assets | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable and other current and non-current liabilities | |||||
| Accrued expense for estimated legal contingency | |||||
| Accrued compensation | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Payments for technology licenses | |||||
| Cost of acquisitions, net | |||||
| Proceeds from maturities and sales of marketable securities and investments | |||||
| Proceeds from sale of equipment and an intangible asset | |||||
| Proceeds from sales of marketable securities and investments | |||||
| Proceeds from maturities of marketable securities and investments | |||||
| Purchases of marketable securities and investments | |||||
| Transfer to restricted cash | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from the issuance of common shares and exercise of stock options | |||||
| Excess tax benefits from stock-based compensation | |||||
| Proceeds from bank borrowing | |||||
| Proceeds from borrowings of convertible senior notes, net of issuance costs | |||||
| Purchase of convertible note capped call hedge | |||||
| Principal payments of notes payable | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rate change on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
Loading...